Evidence map›Paper›PMID 23657818›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2013

Loss of actomyosin regulation in distal arthrogryposis myopathy due to mutant myosin binding protein-C slow.

Maegen A Ackermann, Puja D Patel, Jane Valenti, Yasuharu Takagi, Earl Homsher, James R Sellers, Aikaterini Kontrogianni-Konstantopoulos

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Sarcomeric myopathies associated with tremor: new insights and perspectives.Journal of muscle research and cell motility · 2020
    Article
  9. Skeletal MyBP-C isoforms tune the molecular contractility of divergent skeletal muscle systems.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Structure before function: myosin binding protein-C slow is a structural protein with regulatory properties.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2018
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Maegen A AckermannDepartment of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene St, Baltimore, MD 21201, USA.
Puja D Patel
Jane Valenti
Yasuharu Takagi
Earl Homsher
James R Sellers
Aikaterini Kontrogianni-Konstantopoulos
University of Maryland, Baltimore · USNational Heart Lung and Blood Institute · USNational Institutes of Health · USUniversity of California, Los Angeles · US

Funding

Regulation Of Smooth and Nonmuscle MyosinZIAHL001786 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES · 2009 to 2025
$17.4M
M-Line Proteins and A-Band Assembly in Skeletal MuscleR01AR052768 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI · 2006 to 2010
$1.4M
Role of phosphorylation in cardiac muscle myosinZIAHL006174 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI SELLERS, JAMES · 2013 to 2017
$985k
Novel Locations; Familiar Functions: Obscurin at the Cardiac Intercalated DiscK99HL116778 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI BORZOK, MAEGEN A. · 2013 to 2014
$257k
MyBP-C slow variant 1: a slow isoform in a fast muscleF32AR058079 · NIAMS · UNIVERSITY OF MARYLAND BALTIMORE · PI BORZOK, MAEGEN A. · 2010 to 2012
$159k
Intramural NIH HHSNHLBI NIH HHS K99 HL116778NIAMS NIH HHS F32 AR058079NIAMS NIH HHS F32-AR-058079NIAMS NIH HHS R01 AR052768NIAMS NIH HHS R01-AR-52768
6 · The paper itself

Abstract

Myosin binding protein C (MyBP-C) is expressed in striated muscles, where it plays key roles in the modulation of actomyosin cross-bridges. Slow MyBP-C (sMyBP-C) consists of multiple variants sharing common domains but also containing unique segments within the NH2 and COOH termini. Two missense mutations in the NH2 terminus (W236R) and COOH terminus (Y856H) of sMyBP-C have been causally linked to the development of distal arthrogryposis-1 (DA-1), a severe skeletal muscle disorder. Using a combination of in vitro binding and motility assays, we show that the COOH terminus mediates binding of sMyBP-C to thick filaments, while the NH2 terminus modulates the formation of actomyosin cross-bridges in a variant-specific manner. Consistent with this, a recombinant NH2-terminal peptide that excludes residues 34-59 reduces the sliding velocity of actin filaments past myosin heads from 9.0 ± 1.3 to 5.7 ± 1.0 μm/s at 0.1 μM, while a recombinant peptide that excludes residues 21-59 fails to do so. Notably, the actomyosin regulatory properties of sMyBP-C are completely abolished by the presence of the DA-1 mutations. In summary, our studies are the first to show that the NH2 and COOH termini of sMyBP-C have distinct functions, which are regulated by differential splicing, and are compromized by the presence of missense point mutations linked to muscle disease.

Indexed as

ActinsActomyosinAlternative SplicingAmino Acid SubstitutionAnimalsArthrogryposisBinding SitesBlotting, Far-WesternCarrier ProteinsDistal MyopathiesHumansMiceModels, BiologicalModels, MolecularMuscle, SkeletalMutationActinsActomyosinCarrier ProteinsMyosin Binding Protein CMyosinsactincontractilityMYBPC1skeletal muscle

Identifiers

PMID23657818
PMCPMC3714579
OpenAlexW2128140075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.